首页|基于单组目标值法益肾祛浊方治疗肥胖型PCOS异常子宫出血疗效及代谢机制研究

基于单组目标值法益肾祛浊方治疗肥胖型PCOS异常子宫出血疗效及代谢机制研究

扫码查看
目的 采用单组目标值法,探讨益肾祛浊方治疗肥胖型多囊卵巢综合征(PCOS)异常子宫出血的临床疗效及安全性,并运用代谢组学技术探讨其作用机制.方法 选取 2022 年 1月—2023 年6 月在首都医科大学附属北京中医医院妇科门诊确诊为肥胖型PCOS异常子宫出血,辨证为脾肾两虚、阳明浊热证的患者80 例,给予益肾祛浊方治疗12 周.观察治疗前后血清性激素[睾酮(T)、卵泡刺激素(FSH)、黄体生成素(LH)、雌二醇(E2)、孕酮(P)、抗苗勒管激素(AMH)]水平、妊娠率、基础体温(BBT)排卵率、月经失血图(PBAC)评分、出血时间、中医证候积分、肥胖指标[体重、体质指数(BMI)、腰围、臀围、腰臀比]、糖脂代谢指标[空腹胰岛素(FINS)、空腹血糖(FPG)、胰岛素抵抗指数(HOMA-IR)、总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、载脂蛋白A1(Apo A1)、载脂蛋白B(Apo B)、小而密低密度脂蛋白胆固醇(sd LDL-C)、同型半胱氨酸(Hcy)]、超声检查指标(子宫内膜厚度、卵巢体积、卵泡数目)、炎症因子指标[白细胞介素(IL)-2、IL-4、IL-6、IL-17、肿瘤坏死因子-α(TNF-α)]及安全性,并运用代谢组学技术筛选患者治疗前后粪便差异代谢物及通路.结果 治疗12 周后血清T水平为(60.13±26.49)ng/dL,95%置信区间上限低于目标值,点估计值优于靶值.治疗后妊娠率达到 26.67%(8/30);BBT 排卵率及血清 HDL-C、Apo A1 水平均明显高于治疗前(P 均<0.05),PBAC评分、中医证候积分、出血时间、体重、BMI、腰围、臀围、腰臀比及血清LH、LH/FSH、FPG、FINS、HOMA-IR、TC、LDL-C、Apo B、sd LDL-C、IL-2、IL-6、TNF-α水平均明显低于治疗前(P均<0.05),卵泡数目明显少于治疗前(P<0.05);无严重不良反应.治疗前后粪便代谢组学研究共鉴定出96 种差异代谢物,筛选出71 条通路.结论 益肾祛浊方可有效治疗肥胖型PCOS患者的肥胖及异常子宫出血,提高BBT排卵率,促进妊娠,纠正激素失衡、胰岛素抵抗及其糖脂代谢紊乱,改善超声下卵巢多囊样变及慢性炎症状态,且安全.该方药对患者体内的代谢路径产生积极影响,从多个环节对PCOS患者产生调节作用.
Efficacy and metabolic mechanism of decoction for replenishing kidney and dispelling turbid on abnormal uterine bleeding in obese PCOS based on single-arm objective performance criteria
Objective It is to explore the clinical efficacy and safety of decoction for replenishing kidney and dispelling turbid in the treatment of abnormal uterine bleeding in obese polycystic ovary syndrome(PCOS)by single-arm objective performance criteria,and to explore its mechanism by metabolomics technology.Methods Eighty patients who were diag-nosed as obese PCOS with abnormal uterine bleeding and identified as syndrome of splee-kidney deficiency and Yangming turbid-heat in the gynecology outpatient clinic of Beijing Hospital of Traditional Chinese Medicine from January 2022 to June 2023 were selected and treated with decoction for replenishing kidney and dispelling turbid for 12 weeks.The serum levels of sex hormones[testosterone(T),follicle stimulating hormone(FSH),luteinizing hormone(LH),estradiol(E2),pro-gesterone(P),anti-mullerian hormone(AMH)]before and after treatment,pregnancy rate after treatment,basal body temperature(BBT)ovulation rate,Pictorial Blood Loss Assessment Chart(PBAC)scores,bleeding time,Chinese medi-cine syndrome scores,obesity indicators[weight,body mass index(BMI),waist circumference,hip circumference,waist-to-hip ratio],indicators of glucose and lipid metabolism[fasting insulin(FINS),fasting glucose(FPG),insulin re-sistance index(HOMA-IR),total cholesterol(TC),triacylglycerol(TG),low-density lipoprotein cholesterol(LDL-C),high-density lipoprotein cholesterol(HDL-C),apolipoprotein A1(Apo A1),apolipoprotein B(Apo B),small dense-low-density lipoprotein cholesterol(sdLDL-C),homocysteine(Hcy)],ultrasonographic indicators(endometrial thickness,o-varian volume,follicle number),inflammatory factor indicators[interleukin(IL)-2,IL-4,IL-6,IL-17,tumor necrosis factor-α(TNF-α)]before and after treatment and safety were observed,and metabolomics was used to screen the fecal dif-ferential metabolites and pathways before and after treatment in the patients.Results The serum level of T was(60.13±26.49)ng/dL after12 weeks of treatment,its upper limit of the95%confidence interval was lower than the target value and the point estimate was better than the target value.The pregnancy rate reached 26.67%(8/30)after treatment;the BBT ovulation rate and serum levels of HDL-C and Apo A1 were significantly higher than those before treatment(all P<0.05),and the PBAC scores,Chinese medicine syndrome scores,bleeding time,weight,BMI,waist circumference,hip circumference,waist-hip ratio,and serum levels of LH,LH/FSH,FPG,FINS,HOMA-IR,TC,LDL-C,Apo B,sd LDL-C,IL-2,IL-6,and TNF-α were significantly lower than those before treatment(all P<0.05),and the number of follicles was significantly less than that before treatment(all P<0.05);there were no serious adverse reactions occurred.Fecal metabolomics studies before and after treatment identified 96 differential metabolites and screened 71 pathways.Conclusion Decoction for replenishing kidney and dispelling turbid can is effective in the treatment of obesity and abnormal uterine bleeding in obese PCOS patients,it can increase the ovulation rate of BBT,promote pregnancy,correct hormonal imbal-ance,insulin resistance and disorders of glucose and lipid metabolism,and improve the state of ultrasound-induced ovarian polycystic degeneration and chronic inflammation with good safety.The decoction positively affects the metabolic pathways and modulates PCOS patients in several ways.

polycystic ovary syndromeabnormal uterine bleedingobesitydecoction for replenishing kidney and dis-pelling turbidmetabolomics

高征、李梦元、张雅冬、梁婧翘、许昕

展开 >

首都医科大学附属北京中医医院,北京 100010

首都医科大学中医药临床医学院,北京 100010

多囊卵巢综合征 异常子宫出血 肥胖 益肾祛浊方 代谢组学

2024

现代中西医结合杂志
中国中西医结合学会河北分会,中华中医药学会

现代中西医结合杂志

CSTPCD
影响因子:1.775
ISSN:1008-8849
年,卷(期):2024.33(20)